Stock Track | LifeStance Health Soars 13.31% Pre-market on Strong Q3 Results and Raised Guidance

Stock Track11-06

LifeStance Health Group, Inc. (NASDAQ: LFST) shares surged 13.31% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The outpatient mental healthcare provider reported better-than-expected revenue and earnings, while also raising its full-year guidance.

For the third quarter, LifeStance reported revenue of $363.8 million, a 16% increase year-over-year and surpassing analyst expectations of $355.6 million. The company achieved a net income of $1.1 million, marking a significant turnaround from the $6.0 million loss in the same period last year. Adjusted EBITDA rose 31% to $40.2 million, beating estimates of $35.16 million.

The strong performance was driven by a 17% increase in visit volumes, attributed to net clinician growth and improved productivity. LifeStance's clinician base grew 11% to 7,996, contributing to the revenue and visit volume increases. In light of these results, the company reiterated its full-year 2025 revenue guidance of $1.41 billion to $1.43 billion and raised its Adjusted EBITDA expectations to $146 million to $152 million. The positive outlook and improved operational efficiency have clearly resonated with investors, leading to the significant pre-market stock price jump.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1115726976?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 21:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115726976","market":"nz","top_or_hot":-1,"title":"Stock Track | LifeStance Health Soars 13.31% Pre-market on Strong Q3 Results and Raised Guidance","media":"Stock Track","content":"<p>LifeStance Health Group, Inc. (NASDAQ: LFST) shares surged 13.31% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The outpatient mental healthcare provider reported better-than-expected revenue and earnings, while also raising its full-year guidance.</p>\n\n<p>For the third quarter, LifeStance reported revenue of $363.8 million, a 16% increase year-over-year and surpassing analyst expectations of $355.6 million. The company achieved a net income of $1.1 million, marking a significant turnaround from the $6.0 million loss in the same period last year. Adjusted EBITDA rose 31% to $40.2 million, beating estimates of $35.16 million.</p>\n\n<p>The strong performance was driven by a 17% increase in visit volumes, attributed to net clinician growth and improved productivity. LifeStance's clinician base grew 11% to 7,996, contributing to the revenue and visit volume increases. In light of these results, the company reiterated its full-year 2025 revenue guidance of $1.41 billion to $1.43 billion and raised its Adjusted EBITDA expectations to $146 million to $152 million. The positive outlook and improved operational efficiency have clearly resonated with investors, leading to the significant pre-market stock price jump.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | LifeStance Health Soars 13.31% Pre-market on Strong Q3 Results and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | LifeStance Health Soars 13.31% Pre-market on Strong Q3 Results and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-06 21:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LifeStance Health Group, Inc. (NASDAQ: LFST) shares surged 13.31% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The outpatient mental healthcare provider reported better-than-expected revenue and earnings, while also raising its full-year guidance.</p>\n\n<p>For the third quarter, LifeStance reported revenue of $363.8 million, a 16% increase year-over-year and surpassing analyst expectations of $355.6 million. The company achieved a net income of $1.1 million, marking a significant turnaround from the $6.0 million loss in the same period last year. Adjusted EBITDA rose 31% to $40.2 million, beating estimates of $35.16 million.</p>\n\n<p>The strong performance was driven by a 17% increase in visit volumes, attributed to net clinician growth and improved productivity. LifeStance's clinician base grew 11% to 7,996, contributing to the revenue and visit volume increases. In light of these results, the company reiterated its full-year 2025 revenue guidance of $1.41 billion to $1.43 billion and raised its Adjusted EBITDA expectations to $146 million to $152 million. The positive outlook and improved operational efficiency have clearly resonated with investors, leading to the significant pre-market stock price jump.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LFST","symbol_name":"LifeStance Health Group, Inc.","start_time":0,"source_url":"","article_id":"1115726976","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115726976","pubTimestamp":1762434249,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"LifeStance Health Group, Inc. (NASDAQ: LFST) shares surged 13.31% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The outpatient mental...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LFST":"LifeStance Health Group, Inc."},"translate_title":"个股赛道|LifeStance Health盘前大涨13.31%Q3业绩强劲且指引上调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFST":1},"content_text":"LifeStance Health Group, Inc. (NASDAQ: LFST) shares surged 13.31% in pre-market trading on Thursday following the release of its impressive third-quarter 2025 financial results. The outpatient mental healthcare provider reported better-than-expected revenue and earnings, while also raising its full-year guidance.\nFor the third quarter, LifeStance reported revenue of $363.8 million, a 16% increase year-over-year and surpassing analyst expectations of $355.6 million. The company achieved a net income of $1.1 million, marking a significant turnaround from the $6.0 million loss in the same period last year. Adjusted EBITDA rose 31% to $40.2 million, beating estimates of $35.16 million.\nThe strong performance was driven by a 17% increase in visit volumes, attributed to net clinician growth and improved productivity. LifeStance's clinician base grew 11% to 7,996, contributing to the revenue and visit volume increases. In light of these results, the company reiterated its full-year 2025 revenue guidance of $1.41 billion to $1.43 billion and raised its Adjusted EBITDA expectations to $146 million to $152 million. The positive outlook and improved operational efficiency have clearly resonated with investors, leading to the significant pre-market stock price jump.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1115726976","isCrawlerRequest":true}